---
figid: PMC9495514__antioxidants-11-01705-g009
pmcid: PMC9495514
image_filename: antioxidants-11-01705-g009.jpg
figure_link: /pmc/articles/PMC9495514/figure/antioxidants-11-01705-f009/
number: Figure 9
figure_title: ''
caption: 'ICS II attenuated insulin resistance in PA-induced HepG2 cells by regulating
  the IRS1/Akt signaling transduction pathway. (a) Representative western blot of
  phosphorylation level of IRTyr 1185 and IRS1Ser 307. (b) Quantitation of phosphorylation
  level of IRTyr 1185 (n = 5). (c) Quantitation of phosphorylation level of IRS1Ser
  307 (n = 5). (d) Representative western blot of phosphorylation level of GSK3βSer
  9 and Akt. (e) Quantitation of phosphorylation level of GSK3βSer 9. (f) Quantitation
  of phosphorylation level of Akt (n = 5). Data were expressed as mean ± SEM. ** p
  < 0.01 versus control group; #p < 0.05 and ##p < 0.01 versus PA 300 group.'
article_title: 'Icariside II Exerts Anti-Type 2 Diabetic Effect by Targeting PPARα/γ:
  Involvement of ROS/NF-κB/IRS1 Signaling Pathway.'
citation: Yiqi Li, et al. Antioxidants (Basel). 2022 Sep;11(9):1705.
year: '2022'

doi: 10.3390/antiox11091705
journal_title: Antioxidants
journal_nlm_ta: Antioxidants (Basel)
publisher_name: MDPI

keywords:
- Icariside II
- Type 2 diabetes mellitus
- peroxisome proliferator-activated receptors α and γ
- oxidative stress
- inflammation

---
